GG
BIIB icon

Gofen & Glossberg’s Biogen BIIB Stock Holding History

Gofen & Glossberg’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$206K Buy
+745
New +$210K 0.01% 521
2014
Q2 		– Sell
-245
Closed -$83K – 457
2014
Q1 		$83K Hold
245
– – ﹤0.01% 481
2013
Q4 		$68K Buy
+245
New +$63.4K ﹤0.01% 486

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gofen & Glossberg's BIIB Position: Q4 2022 in Review

Gofen & Glossberg opened a new position in Biogen (BIIB) in Q4 2022: 745 shares worth $206K. The stake represents 0.01% of the portfolio and ranks #521 among its holdings. This is a return to the name: Gofen & Glossberg previously reported a position in BIIB as recently as Q1 2014.

Gofen & Glossberg first reported a position in BIIB in Q4 2013 and has held it in 3 quarters since. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • Gofen & Glossberg held 745 shares of Biogen worth $206K as of Q4 2022.
  • Biogen was a new Gofen & Glossberg position in Q4 2022.
  • Biogen made up 0.01% of Gofen & Glossberg's portfolio in Q4 2022, its #521 holding.
  • Gofen & Glossberg first reported a position in Biogen in Q4 2013 and has held it in 3 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.